Latest Isomorphic Labs news, funding rounds and robotics & AI coverage. 1 article tracked by The Robotics Media.
Isomorphic Labs is a London-based AI-first drug discovery company founded in 2021 as an Alphabet spin-out from Google DeepMind. Led by DeepMind co-founder Demis Hassabis, the company applies models rooted in AlphaFold and other AI systems to design new medicines, in partnerships with pharmaceutical companies including Novartis and Eli Lilly.